Intrexon | XON - Marktkapitalisierung

Aktienkurs
4.14
Täglich Wechseln
-0.02 -0.48%
Monatlich
17.95%
Jährlich
195.71%
Q2 Prognose
4.05




Marktkapitalisierung Veränderung Datum
Agenus USD 107M 16M 2025-12
Alaunos Therapeutics USD 5M 5M 2025-09
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
MacroGenics USD 102M 4M 2025-12
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Veracyte USD 3.33B 627M 2025-12
Xencor USD 1.09B 256M 2025-12